Abstract 18296: Association of SGLT2 Inhibitor Therapy with Long-Term Outcomes Following Aortic Valve Replacement: A Danish Registry Analysis
Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have emerged as an important therapy for heart failure and have favorable effects on myocardial remodeling, fibrosis, and inflammation. The overlap between aortic stenosis (AS) and heart failure with preserved ejection fraction provides a rationale for e...